J. Hartig

Building effective institutional frameworks to support pharmacogenetic research: An international empirical analysis (2009)

Gaisser, S., Dreiling, M., Hartig, J., Hopkins, M.M., Ryan, J., Ibarreta, D.

As science unravels the genetic basis of disease, the opportunities offered by pharmacogenetics and pharmacogenomics (PGx) for future healthcare become more and more apparent. The objective of this...

Wettbewerbsfähigkeit und Standortattraktivität Deutschlands im Zukunftsmarkt Gesundheit (2008)

Nusser, M., Gaisser, S., Hartig, J., Wydra, S.

Die Attraktivität Deutschlands als F&E-Standort sowie die Wettbewerbsposition der deutschen Pharmaindustrie hat sich zwischen 1975 und 1995 deutlich verschlechtert. Aktuelle Studienergebnisse für...

Potenzialstudie "Anwendungspotenziale der Bioverfahrenstechnik (weiße Biotechnologie) in Nordrhein-Westfalen": Projektkurzname: Studie Anwendung IBT NRW (2008)

Pflaum, H., Kabasci, S., Merrettig-Bruns, U., Rettweiler, M., Sayder, B., Schnell, U., ...

Wissensbasis, Technologietransfer und Marktattraktivität: Deutschlands Wettbewerbsposition im internationalen Vergleich (2008)

Nusser, M., Wydra, S., Hartig, J.

Der Gesundheitsstandort Deutschland scheint derzeit gut positioniert zu sein. Vor allem bei der Verfügbarkeit von qualifiziertem Personal und der Marktattraktivität, aber auch bei der Qualität der...

Individualisierte Medizin und Gesundheitssystem (2008)

Hüsing, B., Hartig, J., Bührlen, B., Reiß, T., Gaisser, S.

Individualisierte Medizin und Gesundheitssystem (2008)

Hüsing, B., Hartig, J., Bührlen, B., Reiß, T., Gaisser, S.

Forschungs- und wissensintensive Branchen: Optionen zur Stärkung ihrer internationalen Wettbewerbsfähigkeit (2007)

Nusser, M., Wydra, S., Hartig, J., Gaisser, S.

Forschungs- und wissensintensive Branchen: Optionen zur Stärkung ihrer internationalen Wettbewerbsfähigkeit (2007)

Nusser, M., Wydra, S., Hartig, J., Gaisser, S.

Muon Spin Relaxation Studies of Superconductivity in a Crystalline Array of Weakly Coupled Metal Nanoparticles (2006)

Bono, D., Schnepf, A., Hartig, J., Schnöckel, H., Nieuwenhuys, G.J., Amato, A., ...

We report Muon Spin Relaxation studies in weak transverse fields of the superconductivity in the metal cluster compound,...

Muon Spin Relaxation Studies of Superconductivity in a Crystalline Array of Weakly Coupled Metal Nanoparticles (2006)

Bono, D., Schnepf, A., Hartig, J., Schnöckel, H., Nieuwenhuys, G. J., Amato, A., ...

We report Muon Spin Relaxation studies in weak transverse fields of the superconductivity in the metal cluster compound, Ga$\_{84}$[N(SiMe$\_{3}$)$\_{2}$]$\_{20}$-Li$\_{6}$Br$\_{2}$(thf)$\_{20}\cdot...

Muon Spin Relaxation Studies of Superconductivity in a Crystalline Array of Weakly Coupled Metal Nanoparticles (2006)

Bono, D., Schnepf, A., Hartig, J., Schnöckel, H., Nieuwenhuys, G.J., Amato, A., ...

We report Muon Spin Relaxation studies in weak transverse fields of the superconductivity in the metal cluster compound,...

Muon Spin Relaxation Studies of Superconductivity in a Crystalline Array of Weakly Coupled Metal Nanoparticles (2006)

Bono, D., Schnepf, A., Hartig, J., Schnöckel, H., Nieuwenhuys, G.J., Amato, A., ...

We report Muon Spin Relaxation studies in weak transverse fields of the superconductivity in the metal cluster compound,...

Putting pharmacogenetics into practice (2006)

Hopkins, M.M., Ibarreta, D., Gaisser, S., Enzing, C.M., Hartig, J.

Genetics is slowly explaining variations in drug response, but applying this knowledge depends on implementation of a host of policies that provide long-term support to the field, from translational...

Regulatory and Quality Assurance Frameworks for PGX. A Comparative Study of the US, EU and Four EU Member States: Part 3 of an ESTO Study on Pharmacogenetics and Pharmacogenomics. State of the Art and Social and Economic Impacts (2006)

Hopkins, M.M., Lewis, G., Gaisser, S., Ryan, J., Enzing, C., Hartig, J., ...

Global R&D Activities Related to Pharmacogenetics and Pharmacogenomics: Part 1 of an ESTO Study on Pharmacogenetics and Pharmacogenomics: State of the Art and Social and Economic Impacts (2006)

Gaisser, S., Dreiling, M., Hartig, J., Hopkins, M., Martin, P., Nightingale, P., ...

Case studies and cost-benefit analysis of HER2 and TPMT in four EU member states: Part 2 of an ESTO study on pharmacogenetics and pharmacogenomics: State of the art and social and economic impacts (2006)

Enzing, C., Detmar, S., Vullings, W., Hedgecoe, A., Hopkins, M.M., ...

Muon Spin Relaxation Studies of Superconductivity in a Crystalline Array of Weakly Coupled Metal Nanoparticles (2006)

Bono, D., Schnepf, A., Hartig, J., Schnöckel, H., Nieuwenhuys, G.J., Amato, A., ...

We report Muon Spin Relaxation studies in weak transverse fields of the superconductivity in the metal cluster compound,...

Electron attachment to negative fullerene ions: a Fourier transform mass spectrometric study. (2003)

Hartig, J., Blom, M.N., Hampe, O., Kappes, M.M.

International Journal of Mass Spectrometry, 229(2003) S.93-98

Interactive visualization of large scalar voxel fields (1992)

Hartig, J., Sakas, G.

We present a technique allowing interactive visualization of large, scalar, discrete volume fields as semi-transparent clouds "on the fly", i.e., without preprocessing. Interactivity is not...